CD163 and neoplasm: We found that tumor implantation into macrophagic NLRP3-depleted mice significantly reduced CD163-CD68+ M1 macrophages and significantly increased CD163+CD68+ M2 macrophages compared to tumor implantation into control mice (Figures 6A, B).